MRC CiC6.1 - Immunological Validation of Der p 1 Peptides for Treatment of House Dust Mite Allergy

Wraith, David (Principal Investigator)

Immunology and Immunotherapy

Short title	MRC CiC6.1 - Immunological Validation of Der p 1 Peptides for Treatment of House Dust Mite Allergy
Status	Finished
Effective start/end date	1/11/18 → 31/12/21

Funding

Medical Research Council

A dominant, pan-DR binding epitope of Der p 1 in house dust mite allergy induces tolerance in HLA-DR4 transgenic mice
Streeter, H. B., Lucas, L. G., West, R. M., Krishna, M. T. & Wraith, D. C., 11 Apr 2025, In: Frontiers in immunology. 16, 11 p., 1569283.
Research output: Contribution to journal › Article › peer-review

Open Access
File
3 Downloads (Pure)